Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II. - Université de Lille Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Cancers Année : 2020

Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II.

Résumé

Organometallics, such as copper compounds, are cancer chemotherapeutics used alone or in combination with other drugs. One small group of copper complexes exerts an effective inhibitory action on topoisomerases, which participate in the regulation of DNA topology. Copper complexes inhibitors of topoisomerases 1 and 2 work by different molecular mechanisms, analyzed herein. They allow genesis of DNA breaks after the formation of a ternary complex, or act in a catalytic mode, often display DNA intercalative properties and ROS production, and sometimes display dual effects. These amplified actions have repercussions on the cell cycle checkpoints and death effectors. Copper complexes of topoisomerase inhibitors are analyzed in a broader synthetic view and in the context of cancer cell mutations. Finally, new emerging treatment aspects are depicted to encourage the expansion of this family of highly active anticancer drugs and to expend their use in clinical trials and future cancer therapy.
Fichier principal
Vignette du fichier
P20.28 Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II..pdf (3.64 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03125689 , version 1 (29-01-2021)
hal-03125689 , version 2 (16-11-2023)

Licence

Identifiants

Citer

Caroline Molinaro, Alain Martoriati, Lydie Pelinski, Katia Cailliau. Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II.. Cancers, 2020, Cancers, 12 (10), pp.2863. ⟨10.3390/cancers12102863⟩. ⟨hal-03125689v2⟩
40 Consultations
63 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More